US Bancorp
CELZ icon

US Bancorp’s Creative Medical Technology CELZ Stock Holding History

US Bancorp’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-300
Closed -$1.14K – 4099
2022
Q4 		$1.14K Hold
300
– – ﹤0.01% 3901
2022
Q3 		$1K Hold
300
– – ﹤0.01% 3922
2022
Q2 		$2K Hold
300
– – ﹤0.01% 3802
2022
Q1 		$12K Buy
300
+200
+200% +$4.45K ﹤0.01% 3306
2021
Q4 		$2K Buy
+100
New +$2.1K ﹤0.01% 3867

Other funds holding CELZ

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

US Bancorp's CELZ Position: Q1 2023 in Review

US Bancorp sold out of Creative Medical Technology (CELZ) in Q1 2023, closing a stake of 300 shares — an estimated $1.14K sold.

US Bancorp first reported a position in CELZ in Q4 2021 and held it in 5 quarters. The position peaked at $12K in Q1 2022. 15 funds tracked by Wall St. Rank hold CELZ as of Q1 2023.

  • US Bancorp reported no remaining Creative Medical Technology position as of Q1 2023 after selling out during the quarter.
  • US Bancorp sold 300 Creative Medical Technology shares in Q1 2023, an estimated $1.14K.
  • US Bancorp first reported a position in Creative Medical Technology in Q4 2021 and held it in 5 quarters.
  • US Bancorp's Creative Medical Technology position peaked at $12K in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.